PRESS RELEASE
News
-
-
-
PRESS RELEASE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052, Temporary Interruption of Share Repurchase Program
Alzchem Group AG temporarily interrupts its share repurchase program to prepare the Annual Accounts 2024 based on stable figures, to be resumed on January 2, 2025 -
PRESS RELEASE
GENERALIFX Unveils Multimillion-Dollar AI Strategy Autopilot to Revolutionize Trading
GENERALIFX launches Multimillion-Dollar AI Strategy Autopilot, empowering investors with AI-driven trading precision and performance. Backed by myfxbook results and 5-star Trustpilot ratings, GENERALIFX offers innovative solutions and educational resources for traders worldwide -
PRESS RELEASE
EsoCap announces publication of comprehensive Phase II results demonstrating ESO-101’s effectiveness in eosinophilic esophagitis
EsoCap AG announces Phase II results of ESO-101 for eosinophilic esophagitis treatment published in Alimentary Pharmacology & Therapeutics. Study shows safety, efficacy, and high patient satisfaction -
-
-
PRESS RELEASE
The Glimpse Group Issues 2024 Year End Shareholder Letter Highlighting Spatial Core Market Traction and Expected Profitability
The Glimpse Group's President & CEO summarizes key developments for 2024, focusing on Spatial Core AI and Cloud Revenues, DoD contracts, revenue growth, and profitability, positioning the company for future success -
-
